HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS/Eckerd deal

This article was originally published in The Rose Sheet

Executive Summary

CVS will voluntarily refile its pre-merger notification and report form to comply with a request from the Federal Trade Commission, company announces May 14. The retailer's original April 16 submission prompted an informal request from FTC staff for additional information regarding the transaction, in which CVS will purchase about 1,260 Eckerd stores from J.C. Penney (1"The Rose Sheet" April 12, 2004, In Brief). The refiling allows FTC more time to "review the information submitted by CVS before the staff must determine what additional information, if any, it will formally request," according to CVS...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012147

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel